Status:
COMPLETED
Xray Volume Imaging (Cone Beam CT) - Prostate Cancer
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Canadian Association of Radiation Oncology
Conditions:
Prostatic Neoplasms
Eligibility:
MALE
18+ years
Phase:
PHASE2
Brief Summary
Conformal dose escalated radiotherapy was adopted as the standard treatment technique at PMH for intermediate risk patients with localised disease in 1997. This technique provides a much smaller margi...
Eligibility Criteria
Inclusion
- Diagnosis of adenocarcinoma of the prostate
- Patient undergoing escalated dose conformal external beam radiotherapy.
- Patient has low or intermediate risk prognostic factors: all of PSA \<21, Gleason score \<8, clinical T category \<T3, clinical N category 0 or X, M category 0 or X.
- Informed consent
Exclusion
- No diagnosis of adenocarcinoma of the prostate
- Patient not undergoing escalated dose conformal radiotherapy
- Patient does not have low or intermediate risk prognostic factors
Key Trial Info
Start Date :
November 1 2003
Trial Type :
INTERVENTIONAL
End Date :
November 1 2004
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00188799
Start Date
November 1 2003
End Date
November 1 2004
Last Update
July 16 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9